Research Use Only — Confirm to Continue

OptimalDosages.com publishes reference material for laboratory and educational use. Nothing here is medical advice, a prescription, or a recommendation for human administration.

By continuing you confirm you are 21 or older and that you are accessing this material in a research or educational capacity.

Research Use Only · Dosing data compiled from published literature · Not for human or veterinary use

MOTS-c Dosage & Reconstitution

Mitochondrial ORF of the 12S rRNA type-c. Work out exactly what to draw for your own mix, see the doses used in research, and follow a week-by-week plan. Evidence tier: preclinical.

1Set Up Your Mix

40 mg/mL · 40000 mcg/mL
All answers assume a standard 1 mL U-100 syringe, where 1 unit = 0.01 mL. That is the usual insulin syringe and the one every number here is based on.

Your Answer — MOTS-cYour Answer

25Draw To This Line
0.25That's This Many mL
4Doses In The Vial
0102030405060708090100 U-100 syringe · 1 mL · 100 units draw to 25
40 mg ÷ 1 mL = 40 mg/mL  →  10 mg ÷ 40 mg/mL = 0.25 mL  →  × 100 = 25 units
Looks good. Draw to 25 units on a 1 mL syringe. That is an easy amount to measure, and this vial gives you 4 doses.

2Week-By-Week Plan — MOTS-c

Start low, work up
WhenDoseHow OftenHow Many mLDraw ToNumber Of DosesPeptide Used
Low reported 5 mg 2–3× weekly 0.125 mL 12.5 u 8 doses
Standard 10 mg 2–3× weekly 0.25 mL 25 u 4 doses
Research study dose0.5–5 mg/kg weight-baseddaily Set by body weight — can't be turned into a single amount to draw
Weeks until the top dose
2 weeks
Peptide used getting there
25 mg
Vials you'll need
1 × 40 mg
Once you're at the top dose
100 mg / 4 wk · 2.5 vials
Where this plan came from
Built from this peptide's dose range
Where this came from: Built from the doses listed for this peptide below — start at the lowest and step up, using the studies cited on this page. Nobody publishes a week-by-week plan for this peptide, so we built one: the doses are the researched ones shown below, and we simply put them in order from lowest to highest. Treat it as a starting point, not an official schedule.

3Common Doses — MOTS-c

worked out for your mix
LevelDoseHow OftenHow Many mLDraw ToDoses In Vial
Weeks 1–2 5 mg 2.5× weekly 0.125 mL 12.5 u 5 25 mg
Week 3 onward
per 4 weeks from here on
10 mg 2.5× weekly 0.25 mL 25 u 10 100 mg
Please read this. These numbers come from published research. They are here as reference, not as instructions. A lot of them come from lab studies rather than studies in people, and some of these peptides have never been given to a person at all.

About MOTS-cAbout This Peptide

Mitochondrial
Also known as
Mitochondrial ORF of the 12S rRNA type-c
Class
Mitochondrial
Route
Subcutaneous
Half-life
Short
Evidence tier
Preclinical

A mitochondrial-derived peptide acting via AMPK on insulin sensitivity and metabolic homeostasis. Genuinely interesting mechanism with solid research data and human observational correlations, but no human dosing trials.

Buy MOTS-cthis peptide

Opens optimal-pep.com in a new tab

Where These Numbers Come From

Preclinical — Preclinical and in-vitro data only — no human dosing trials
The mitochondrial-derived peptide MOTS-c promotes metabolic homeostasis and reduces obesity and insulin resistance Lee C, et al. Cell Metabolism, 2015
The discovery paper; source of all research dosing figures.
Find on PubMed ↗
MOTS-c in exercise and skeletal muscle adaptation Reynolds JC, et al. Nature Communications, 2021
Extends the mechanism to exercise capacity and healthspan in preclinical models.
Find on PubMed ↗

Newest Studies —

Not reviewed by us. This list is pulled straight from Europe PMC as papers are published. Nobody has checked whether these are any good, or whether they change anything above. The dose numbers on this page only ever change after a person reviews the evidence.

More peptides

Browse the full catalogue, or jump to a neighbouring compound.

NAD+

A coenzyme rather than a peptide. Direct NAD+ administration is bioavailability-limited and often poorly tolerated (stinging, flus…

SS-31

A cardiolipin-targeting mitochondrial peptide — the only compound in this class with substantial registered human trial data, acro…

All 71 peptides

Every compound compared in one table: dose range, how often, half-life and evidence tier.